Organic Active Ingredients TRIZ Cases

Intermittent progesterone antagonist therapy prevents endometrial hyperplasia and reduces pain without increasing cardiovascular or breast cancer risks.

A diagnostic method quantifies ADM-NH2 levels in bodily fluids to guide corticosteroid treatment initiation.

A topical cannabinoid composition combines cannabinoids with humectants and penetration enhancers to deliver localized therapeutic effects.

Ethacrynic acid inhibits the Wnt/beta-catenin pathway to overcome limited efficacy of thalidomide treatments in leukemia.

Quinolin-8-yl-nicotinamide small molecules activate stress response pathways and induce autophagy in cancer cells.

Dual-coated cholestyramine pellets target the colon to resolve bile acid malabsorption while minimizing gastrointestinal side effects.

Inhibiting QPCT enzymes prevents CD47 pyroglutamate formation, blocking SIRPα binding and enhancing immune cell killing without anemia.

SAMTOR links methionine sensing to mTORC1 activation, resolving ambiguity in amino acid regulation.

1,5-Benzothiazepine derivatives inhibit the apical sodium-dependent bile acid transporter to modulate bile acid circulation.

Optimizing ropinirole concentration in the adhesive layer resolves the trade-off between drug permeation and patch adhesiveness.

A displacement competitive inhibition method differentiates specific from unspecific ligand binding in tissue samples using MALDI imaging mass spectrometry.

Fragment-based design of H-pyrrolo[2,3-b]pyridine compounds addresses the lack of effective therapies for SIK2-overexpressed diseases like ovarian cancer.

Minimal HNK-1 disaccharides inhibit anti-MAG IgM binding to resolve unclear epitope recognition in neuropathy diagnosis.

Replacing radiological imaging with PTPμ and PIPK1γ detection resolves the radiation risk trade-off while enabling early scoliosis progression prediction.

Hydrogel releasing D-deoxyribose stimulates angiogenesis, replacing unstable VEGF to resolve cost and stability trade-offs.

A dual microbubble system amplifies ultrasound imaging signals through sequential ligand recruitment at target sites.

Thermally cross-linked albumin-chondroitin sulfate microbeads adsorb anticancer drugs to block liver tumor blood vessels while degrading safely in the body.

FML-saponin vaccine reduces parasite loads and mortality in dogs, replacing toxic chemotherapy and dog slaughter for visceral leishmaniasis control.

EPA and DHA fatty acids improve visual acuity while reducing side effects from traditional steroid treatments.

A small molecule compound binds FIEL1 to inhibit the TGFβ pathway and reduce fibrotic activity.

Chiral asymmetric urea compounds enhance ghrelin receptor binding affinity, reducing side effects while improving therapeutic efficacy for obesity treatment.

HSP90 encoding nucleic acid reduces inflammation in autoimmune disorders where standard therapies fail to alleviate symptoms.

A centrally active phenol compound acts as a dual µ-opioid agonist and noradrenaline uptake inhibitor.

Downregulating TAK1 activity reduces tumor volume and SASP factors, addressing ineffective comprehensive regulation of tumor progression.

Alkyl-substituted pyrazolo[1,5-a]pyrimidines enhance brain penetrance and metabolic stability while avoiding receptor desensitization.

Selective enrichment of Vitis vinifera leaf extracts using membrane filtration or two-phase extraction to concentrate flavonoids and anthocyanins.

3-hydroxyphenyl-2,4-pyrimidinediamine compounds inhibit Fc receptor signaling cascades to prevent adverse events.

CpG oligodeoxynucleotides stimulate vascular endothelial growth factor production in targeted tissues to promote neovascularization.

Intralymphatic injection of GAD-alum targets lymph nodes to enhance immunomodulation and preserve C-peptide secretion in type 1 diabetes.

Polyheterocyclic compounds inhibit METTL3 enzyme activity, addressing the lack of effective treatments for proliferative disorders.

Specific anti-S100A4 antibodies bind circulating S100A4 protein to block pro-angiogenic signaling pathways in tumor microenvironments.

Controlling citric acid particle size suppresses glucose decomposition into 5-hydroxymethyl furfural and reduces acetate intolerance.

Plant-derived flavanone accelerates bone formation without suppressing resorption, resolving the trade-off in osteoporosis treatments.

Substituted tricyclic pyrazolo pyrimidine derivatives provide oral bioavailability and prolonged action to address toxicity risks of existing RSV treatments.

Novel bicyclic aromatic carboxamides inhibit Pim kinases to treat cancer while reducing side effects of existing therapies.

This combination reduces IL-6 and TNF-alpha secretion to eliminate cancer cachexia, pain, and fatigue while maintaining selective malignant cell destruction.

Nickel-superoxide dismutase compounds in haircare formulations scavenge reactive oxygen species to protect follicle cells.

Topical pharmaceutical compositions combine SERPINE1, histone, and IGF inhibitors to target keloid fibroblast proliferation pathways.

Modifying the steroid nucleus reduces arrhythmogenic toxicity while maintaining positive inotropic effects for heart failure treatment.

Extraction of stable Lactobacillus plantarum polysaccharides resolves probiotic safety risks while improving insulin resistance via AMPK activation.

Intralesional HPV vaccine delivery resolves the contradiction between preventive reliability and therapeutic versatility by treating non-HPV associated cancers.

AAV vectors encoding the FXN gene target myocardium tissue to restore frataxin protein levels and improve cardiac function in Friedreich ataxia patients.

Ifetroban administration reduces skin thickness and pulmonary disease mortality by modifying physiological parameters without complex external devices.

A surfactant-modified ophthalmic composition maintains therapeutic efficacy while preventing nozzle residue in multidose preservative-free delivery systems.

Non-carbomer rheology modifiers stabilize the gel structure at 55,000 to 70,000 centipoise, reducing skin irritation and improving storage stability.

Triazole and tetrazole modifications improve solubility and pharmacokinetics while reducing side effects in neuroactive steroid therapies.

Neobeguea mahafalensis extracts provide sexual enhancing effects through isolated chemical compounds.

A cardioplegic solution with controlled calcium ion levels maintains cardiac function during reperfusion.

A sprayable biodegradable gel hardens upon tissue contact to secure drug depots in place.

N-acetylcysteine neutralizes reactive oxygen species to reverse disc degeneration, avoiding the gastrointestinal damage caused by conventional NSAID treatments.

Form II of the pyridazino indole derivative achieves greater solubility through controlled phase transitions, resolving limited drug absorption issues.

Magnesium aluminometasilicate prevents blooming of high-polarity organic fluid components in synthetic rubber adhesive layers, maintaining adhesion.

Enteric coatings mediate gastric contact to minimize irritation while maintaining bioavailability.

A biocleavable conjugate links two distinct anticancer bioactive agents into a single molecular structure.

Formula I bicyclic pyrimidinones overcome Q148K resistance by targeting HIV integrase with distinct chemical structures.

R-ketamine reduces neuronal loss while avoiding S-ketamine side effects.

Formula I thienomethylpiperazine derivatives inhibit soluble epoxide hydrolase to stabilize CYP-P450 epoxides.

Vaccinium macrocarpon leaf extract mitigates metabolic disorders by simultaneously inhibiting MMP-9 and activating PPAR-gamma.

A fentanyl patch uses a styrene-isoprene-styrene adhesive layer to deliver rapid drug permeation through the skin.

Selective α5-GABA inverse agonists reduce proconvulsant adverse effects while restoring cognitive function in neurodegenerative disorders.

Non-ionic surfactants mediate the oil-water interface in protamine nanocapsules, resolving emulsion destabilization caused by protamine's amphiphilic nature.

Engineered hairy root cultures supply therapeutic metabolites without depleting wild plant populations, addressing sustainability and efficacy constraints.

Polymer-coated nanoparticles deliver antisense oligonucleotides to neutralize microRNAs, preventing systemic spread through lymph nodes.

Tricyclic and tetracyclic derivatives of diazepines fused with 1,4-dihydropyridine act as calcium channel blockers.

Local quality and parameter changes optimize selective affinity for PI3K isoforms, resolving insufficient specificity in existing inhibitors.

Polysorbate 80 improves Deferasirox solubility, overcoming poor water solubility for reliable iron overload treatment.

Merges CDC7 inhibitor Compound 1 with PARP inhibitors to overcome limited treatment options and enhance antitumor activity.

PLGA core and PLLA shell microspheres enable tunable delayed release profiles by managing degradation rates.

Tritriacontene compositions trigger honey bees to detect and remove infested brood, resolving toxicity issues from synthetic acaricides.

CR4056 blocks PKCε translocation to reverse memory impairment, overcoming the high failure rate of traditional amyloid-targeting therapies.

A stable pharmaceutical composition using anhydrous Lenalidomide Form I combined with lactose anhydrous to maintain bioavailability.

HOTAIR inhibitors target upstream regulatory molecules to resolve anti-VEGF treatment resistance and adverse effects in diabetic retinopathy.

Dry biocompatible film distributes particulate eggshell membrane uniformly, preventing contamination and uneven application during chronic wound treatment.

Segmenting hOMSC secretomes reveals unique cytokine profiles that enhance diabetic wound healing beyond conventional sources.

Pyrimidine derivatives inhibit phosphatidylinositol 3-kinase activity to reduce tumor growth in proliferative diseases.

Swellable particles inside a permeable container expand when contacted by bodily fluids, anchoring the device in situ for prolonged substance release.

A bispecific antibody formulation uses a composite excipient system to maintain long-term stability at high concentrations.

mPEG-PLA-Phe(Boc) polymer micelles encapsulate ziyuglycoside II, resolving low water solubility and improving bone marrow suppression treatment.

Administering guselkumab to patients who failed prior IL-12/23p40 antibody therapy.

Engineered antibodies target C10orf54-expressing cells to modulate immune responses, resolving autoimmunity risks in cancer therapy.

Standardized criteria assess albumin nanoparticle suitability using cryo-TEM and chromatography to resolve reliability and safety trade-offs.

A porous drug delivery device uses hydrogel-crosslinked microspheres to adsorb and release therapeutic molecules.

Isolating distinct dihydrotetrabenazine stereoisomers improves bioavailability and reduces Parkinsonism risk while maintaining therapeutic efficacy.

Cloning fixes terpene and cannabinoid concentrations, resolving breeding complexity while maintaining genetic diversity.

A sterile injectable aqueous composition combines hyaluronic acid and trehalose to restore skin suppleness and hydration through viscoelastic properties.

A nine-amino acid peptide with cationic and lipophilic residues disrupts tumour cell organelle membranes to release immunostimulatory agents.

Spirocyclic compounds act as MTA-synergistic PRMT5 inhibitors to reduce off-target toxicity in MTAP-deleted cancers.

New ionizable lipid compound forms a delivery carrier for nucleic acid drugs, reducing liver accumulation and toxicity.

Hybrid molecule overcomes compensatory resistance in p53 deficient tumors by inducing synthetic lethality.

siRNA suppresses Zic5 to restore E-cadherin, preventing drug resistance and metastasis in BRAF-inhibitor-resistant melanoma.

Peppermint and orange flavors combined with a viscosity agent mask the bitter taste and numbness of atomoxetine for improved patient compliance.